WY
37
3
VLO
28
2
GE
64
4
IFF
47
3
HOG
29
2
PRU
47
2
DTE
54
5
CFG
40
4
ETR
65
4
JNJ
39
4
ADI
59
2
LH
38
5
PLD
40
2
NEE
44
3
DAL
64
3
BEN
40
3
QRVO
20
2
AIV
40
3
KMB
31
3
AMZN
63
5
WY
37
3
VLO
28
2
GE
64
4
IFF
47
3
HOG
29
2
PRU
47
2
DTE
54
5
CFG
40
4
ETR
65
4
JNJ
39
4
ADI
59
2
LH
38
5
PLD
40
2
NEE
44
3
DAL
64
3
BEN
40
3
QRVO
20
2
AIV
40
3
KMB
31
3
AMZN
63
5
Financhill
Back

Mithra Pharmaceuticals SA 10K Form

Sell
50

MITPF
Mithra Pharmaceuticals SA

Last Price:
$6.75
Seasonality Move:
6.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MITPF News And Ratings

See the #1 stock for the next 7 days that we like better than MITPF

MITPF Financial Statistics

Sales & Book Value

Annual Sales: $70.7M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

Net Income (TTM): $0
Gross Margin: $50M
Return on Equity: 0%
Return on Assets: 0%

Mithra Pharmaceuticals SA Earnings Forecast

Key Mithra Pharmaceuticals SA Financial Ratios

  • The Gross Profit Margin over the past 11 years for MITPF is 70.71%.
  • The Selling, General & Administrative Expenses for MITPF have been equal to 25.04% of Gross Profit Margin.
  • The Research & Development expenses have been 95.59% of Revenue.
  • The Interest Expense is -28.52% of Operating Income.
  • The Net Earning history of MITPF is -88.99% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

Mithra Pharmaceuticals SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: MITPF
Website: mithra.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MITPF Technical Analysis vs Fundamental Analysis

Sell
50
Mithra Pharmaceuticals SA (MITPF) is a Sell

Is Mithra Pharmaceuticals SA a Buy or a Sell?